GTC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Genes to Cells (2004) 9, 1167-1174. doi:10.1111/j.1365-2443.2004.00804.x
© 2004 Blackwell Publishing or its licensors

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaneda, R.
Right arrow Articles by Mano, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaneda, R.
Right arrow Articles by Mano, H.

High-throughput screening of genome fragments bound to differentially acetylated histones

Ruri Kaneda1,2, Minoru Toyota3, Yoshihiro Yamashita1, Koji Koinuma1, Young Lim Choi1, Jun Ota1,4, Hiroyuki Kisanuki1, Madoka Ishikawa1, Shuji Takada1, Kazuyuki Shimada2 and Hiroyuki Mano1,4,*

Divisions of
1 Functional Genomics
2 Cardiology, Jichi Medical School, 3311-1 Yakushiji, Kawachigun, Tochigi 329-0498, Japan
3 Department of Molecular Biology, Cancer Research Institute, Sapporo Medical University, Sapporo 060-8556, Japan
4 CREST, Japan Science and Technology Agency, Saitama 332-0012, Japan

Although acetylation-deacetylation of histones contributes to regulation of gene expression, few methods have been available to determine the whole-genome histone acetylation profile in specific cells or tissues. We have now developed a genome-wide screening method, differential chromatin scanning (DCS), to isolate genome fragments embedded in histones subject to differential acetylation. This DCS screening was applied to a human gastric cancer cell line incubated with or without an inhibitor of histone deacetylase (HDAC) activity, resulting in the rapid identification of more than 250 genome fragments. Interestingly, a number of cancer-related genes were revealed to be the targets of HDAC in the cancer cells, including those for tumour protein 73 and cell division cycle 34. Such differential acetylation of histone was also shown to be linked to the regulation of transcriptional activity of the corresponding genes. Among the isolated genome fragments, 94% (32/34) of them were confirmed to be bound to differentially acetylated histones, and the genes corresponding to 78% (7/9) of them exhibited differential transcriptional activity consistent with the level of histone acetylation. With its high fidelity, the DCS method should open a possibility to rapidly compare the genome-wide histone acetylation profiles and to provide novel insights into molecular carcinogenesis.


Communicated by: Fuyuki Ishikawa

* Correspondence: E-mail: hmano{at}jichi.ac.jp




This article has been cited by other articles:


Home page
Circ. Res.Home page
R. Kaneda, S. Ueno, Y. Yamashita, Y. L. Choi, K. Koinuma, S. Takada, T. Wada, K. Shimada, and H. Mano
Genome-Wide Screening for Target Regions of Histone Deacetylases in Cardiomyocytes
Circ. Res., August 5, 2005; 97(3): 210 - 218.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS
Copyright © 2004 by Wiley-Blackwell Publishing.